Tenders of Aok Plus Die Gesundheitskasse F R Sachsen Und Th Ringen

Tenders of Aok Plus Die Gesundheitskasse F R Sachsen Und Th Ringen

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Germany
Closing Date31 Aug 2026
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Naproxen Exklusive Der Darreichung Sirup (atc-code Nach Who: M01ae02)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+1Civil Works Others
Germany
Closing Date31 Dec 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive drug discount agreement according to Section 130a Paragraph 8 of the Social Security Code V by means of an open-house model for the active ingredient bosutinib (ATC code according to WHO: L01EA04)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+1Civil Works Others
Germany
Closing Date31 Jan 2026
Tender AmountRefer Documents 
Degree Not Exclusive Drug discount association According to Section 130a Paragraph 8 SGB V By way of an open-house model for the active ingredient colistin (atc code according to Who: J01xb01)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Germany
Closing Date30 Sep 2025
Tender AmountRefer Documents 
Conclusion not exclusive of drug discount agreement according to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient epinephrine (ATC code according to WHO: C01CA24) in the form of a pre-filled syringe/pen

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Germany
Closing Date31 Oct 2026
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Distigmin (atc-code Nach Who: N07aa03)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Germany
Closing Date31 Dec 2024
Tender AmountRefer Documents 
Conclusion of non-exclusive drug discount agreements according to Section 130a Paragraph 8 SGB V by way of a so-called Oh model for Ws Golimumab (atc code according to Who: L04ab06) (172/2023-oh)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Others
Germany
Closing Date31 Jan 2026
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Iwe Open-house-modells Zum Wirkstoff Calcipotriol/betamethason (atc-code Who D05ax52), Eingeschränkt Auf Die Darreichung Gel

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Closing Date30 Jun 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive drug discount agreement according to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient combination formoterol/glycopyrronium/budesonide (ATC code according to WHO: R03AL11)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Closing Date31 Jul 2026
Tender AmountRefer Documents 
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open-house model for drugs with the trade name Orylmyte (ATC code according to WHO: V01AA03)

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Aerospace and Defence
Germany
Closing Date31 Mar 2025
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Adalimumab (atc-code Nach Who: L04ab04)
41-50 of 183 active Tenders